Clinical Trials
22 trialsNCT05322330 2026-06-02
Clinical Study of XPO-1 Inhibitors Plus CAR-T Cells in Relapsed Refractory B-cell Non-Hodgkin's Lymphoma
The First Affiliated Hospital of Soochow University
Phase 2 Completed
NCT02518555 2026-04-06
Ibrutinib as an Immune Modulating Agent for Patients With Asymptomatic, High-risk CLL/SLL Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 2 Completed
NCT03955991 2025-06-26
VSMART
University of Miami
Phase 4 Completed
NCT06124131 2025-05-04
BENEFIT-C
Tulane University
Phase NA Completed
NCT04080531 2025-02-28
Influenza Vaccination for Flu Prevention in Patients With Plasma Cell Disorders
Emory University
Phase 4 Completed
NCT02860039 2024-10-22
High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Phase 2 Completed
NCT03061955 2024-10-04
Safety and Efficacy of Concurrent Administration of Influenza Vaccine in Patients Undergoing Anti-PD-1 Immunotherapy (Nivolumab, Pembrolizumab)
Wake Forest University Health Sciences
Completed
NCT04484532 2023-06-06
Evaluation of Antibody Response to High-Dose Seasonal Influenza Vaccination in Patients With Myeloid Malignancy Receiving Chemotherapy and Healthy Volunteers
Roswell Park Cancer Institute
Phase EARLY_PHASE1 Completed
NCT02998736 2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1 Completed
NCT04591379 2022-12-13
Intratumoral Influenza Vaccine for Early Colorectal Cancer
Zealand University Hospital
Phase 2 Completed
NCT02747407 2021-10-29
Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors
Wake Forest University Health Sciences
Completed
NCT03590808 2019-09-19
Influenza Vaccination in Patients Receiving Immune Checkpoint Inhibitor
Seoul National University Hospital
Phase NA Completed
NCT02566265 2019-01-30
SHIVERING 2
Yale University
Phase 2 Completed
NCT01941758 2018-07-05
High-Dose Trivalent Influenza Vaccine in Inducing Immune Response Patients With Central Nervous System Tumors
Wake Forest University Health Sciences
Phase 1 Completed
NCT01474174 2018-07-03
Trivalent Influenza Vaccine in Preventing Flu in Patients With Central Nervous System Tumors
Wake Forest University Health Sciences
Completed
NCT00964821 2017-11-07
Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant
City of Hope Medical Center
Completed
NCT01205581 2016-09-23
Immunogenicity of Fluzone HD,A High Dose Influenza Vaccine, In Children With Cancer or HIV
St. Jude Children's Research Hospital
Phase 2 Completed
NCT01666782 2016-06-24
IMMUNE
Rochester General Hospital
Phase 2 Completed
NCT01707628 2014-01-31
Rituxivac
St. Antonius Hospital
Phase NA Completed
NCT00022035 2013-01-31
Vaccine Therapy in Preventing Flu in Children With Acute Lymphoblastic Leukemia
Roswell Park Cancer Institute
Phase NA Completed
NCT01031719 2012-09-13
Clinical Trial to Compare the Immunogenicity, Safety, and Tolerability of an Adjuvanted A(H1N1) Influenza Vaccine Versus Non-Adjuvanted A(H1N1) Influenza Vaccines in Patients With Invasive Solid Tumors
Chiltern Pesquisa Clinica Ltda
Phase 3 Completed
NCT00979381 2010-03-18
Study of the Immunoresponse in Patients Treated With a Tyrosine Kinase Inhibitor
Radboud University Medical Center
Completed